Cargando…

SIADH and hyponatraemia: foreword

Hyponatraemia is common, affecting about one in five of all hospitalized patients. Minor degrees of chronic hyponatraemia cause cognitive and motor impairment, and severe hyponatraemia is associated with substantial morbidity and mortality. Syndrome of inappropriate antidiuretic hormone secretion (S...

Descripción completa

Detalles Bibliográficos
Autores principales: O’Donoghue, Donal, Trehan, Anu
Formato: Texto
Lenguaje:English
Publicado: Oxford University Press 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2762825/
https://www.ncbi.nlm.nih.gov/pubmed/19881931
http://dx.doi.org/10.1093/ndtplus/sfp152
_version_ 1782172956127920128
author O’Donoghue, Donal
Trehan, Anu
author_facet O’Donoghue, Donal
Trehan, Anu
author_sort O’Donoghue, Donal
collection PubMed
description Hyponatraemia is common, affecting about one in five of all hospitalized patients. Minor degrees of chronic hyponatraemia cause cognitive and motor impairment, and severe hyponatraemia is associated with substantial morbidity and mortality. Syndrome of inappropriate antidiuretic hormone secretion (SIADH) is a common cause of hyponatraemia and is often poorly understood and inappropriately treated. Clinical evaluation and simple biochemical assessment should guide management. The introduction of vasopressin antagonists, or vaptans, into clinical practice heralds the beginning of a new and exciting era for this important group of disorders.
format Text
id pubmed-2762825
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-27628252009-11-01 SIADH and hyponatraemia: foreword O’Donoghue, Donal Trehan, Anu NDT Plus Original Article Hyponatraemia is common, affecting about one in five of all hospitalized patients. Minor degrees of chronic hyponatraemia cause cognitive and motor impairment, and severe hyponatraemia is associated with substantial morbidity and mortality. Syndrome of inappropriate antidiuretic hormone secretion (SIADH) is a common cause of hyponatraemia and is often poorly understood and inappropriately treated. Clinical evaluation and simple biochemical assessment should guide management. The introduction of vasopressin antagonists, or vaptans, into clinical practice heralds the beginning of a new and exciting era for this important group of disorders. Oxford University Press 2009-11 /pmc/articles/PMC2762825/ /pubmed/19881931 http://dx.doi.org/10.1093/ndtplus/sfp152 Text en © The Author 2009. Published by Oxford University Press [on behalf of ERA-EDTA]. http://creativecommons.org/licenses/by-nc/2.0/uk/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.5/uk/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
O’Donoghue, Donal
Trehan, Anu
SIADH and hyponatraemia: foreword
title SIADH and hyponatraemia: foreword
title_full SIADH and hyponatraemia: foreword
title_fullStr SIADH and hyponatraemia: foreword
title_full_unstemmed SIADH and hyponatraemia: foreword
title_short SIADH and hyponatraemia: foreword
title_sort siadh and hyponatraemia: foreword
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2762825/
https://www.ncbi.nlm.nih.gov/pubmed/19881931
http://dx.doi.org/10.1093/ndtplus/sfp152
work_keys_str_mv AT odonoghuedonal siadhandhyponatraemiaforeword
AT trehananu siadhandhyponatraemiaforeword